This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Philly Fed Survey, Jobless Claims & Earnings Data
by Zacks Equity Research
Philly Fed Survey, Jobless Claims & Earnings Data
Storm of Q3 Earnings Results: TRV, BX, PM & More
by Mark Vickery
Earnings reports from calendar Q3 are starting to come in heavier, like a storm of numbers raising the levels of investment discourse.
Philip Morris (PM) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 12.50% and 4.57%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Philip Morris (PM) Q3 Earnings: Cigarette Woes Dim Prospects
by Zacks Equity Research
Philip Morris' (PM) Q3 performance to be hurt by lower cigarette sales volumes. Nevertheless, performance of RRPs is expected to be strong.
Philip Morris (PM) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Philip Morris, PayPal, Dominion, Texas Instruments and PPG
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Philip Morris, PayPal, Dominion, Texas Instruments and PPG
Top Stock Reports for Philip Morris, PayPal & Dominion Energy
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Philip Morris (PM), PayPal (PYPL), and Dominion Energy (D).
Top Stock Reports for Boeing, NVIDIA & Medtronic
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Boeing (BA), NVIDIA (NVDA) and Medtronic (MDT).
What FDA's Stance on E-Cigarettes Means for Tobacco Stocks
by Zacks Equity Research
The FDA announces directives to curb e-cigarette usage among youngsters. Though this caused tobacco stocks to gain recently, it is yet to be seen if the upside can be sustained.
Altria (MO) Shares Up Close to 7% on FDA's Latest Notice
by Zacks Equity Research
The FDA reveals serious enforcement actions related to the marketing and sale of e-cigarettes to minors, which may benefit tobacco players like Altria (MO).
Are Options Traders Betting on a Big Move in Philip Morris (PM) Stock?
by Zacks Equity Research
Investors need to pay close attention to Philip Morris (PM) stock based on the movements in the options market lately.
Wave of Solid Q2 Results Boosts Retail ETFs
by Sweta Killa
Retail has been the hottest sector lately given strong corporate earnings coupled with higher consumer spending and a booming economy.
Altria Hikes Divident by 14.3%, Boosts Shareholders' Value
by Zacks Equity Research
Altria (MO) continues to be committed toward enhancing shareholder value. The company hikes quarterly dividend rates from 70 cents per share to 80 cents.
Juul Labs Faces Lawsuits Due to the Wrong Demographic Using Their Product
by Nimah Quadri
The e-cigarette maker valued at $15 billion is now facing concerns from every corner due to their controversial product.
Altria (MO) Q2 Earnings: Can Smokeless Products Offset Woes?
by Zacks Equity Research
Altria's (MO) Q2 results are likely to gain from rising reduced-risk tobacco products demand. However, soft cigarette volumes are a concern.
Zacks Industry Outlook Highlights: Philip Morris International, Altria Group, British American Tobacco, Imperial Tobacco Group and Turning Point Brands
by Zacks Equity Research
Zacks Industry Outlook Highlights: Philip Morris International, Altria Group, British American Tobacco, Imperial Tobacco Group and Turning Point Brands
Philip Morris (PM) Beats on Q2 Earnings & Sales, Lowers View
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2018 results improve year-on-year on account of strong performance of heated tobacco products.
Philip Morris (PM) Tops Q2 Earnings & Revenues, Stock Loses
by Zacks Equity Research
Phillip Morris (PM) updates outlook on account of certain factors including the impacts from various product and marketing efforts.
Philip Morris (PM) Q2 Earnings: Will RRPs Steal the Show?
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2018 results are likely to gain from rising RRPs demand. However, cigarette volumes will remain soft.
Can Smucker's Shareholder-Friendly Moves Help Revive Stock?
by Zacks Equity Research
Smucker (SJM) announces a quarterly dividend hike of 9% from 78 cents per share to 85 cents. This marks the company's 17th straight year of dividend hike.
Meet Juul, the $15 Billion E-Cig Startup with an Identity Crisis
by Nimah Quadri
In a recent fundraising round, e-cigarette maker Juul Labs Inc. raised $650 million, which values the rapidly-growing, yet still-controversial startup around $15 billion.
Philip Morris (PM) Focused on RRPS, Inks Deal with Parallax
by Zacks Equity Research
Phillip Morris (PM) joins hands with Parallax to develop and expand reduced-risk products in order to counter strict government regulations and changing consumer trends due to health hazards.
Can RRPS, Pricing Aid Revival at Phillip Morris (PM) Stock?
by Zacks Equity Research
Regulatory hurdles and rising health consciousness have been hurting Phillip Morris (PM) cigarette volumes. However, strength in RRPs and solid pricing efforts bode well.
Company News For Jun 11, 2018
by Zacks Equity Research
Companies In The News are: SFIX,DOCU,GE,PM
Philip Morris (PM) Down 5.4% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.